Heidelberg Pharma AG / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €20.57M +42.1% -€33.57M -9.7% -163.2% +0.94 pp N/A N/A
    (estimated) €14.48M +58.3% -€37.17M +13.3% -256.7% +1.0 pp N/A N/A
    (estimated) €9.15M +33.6% -€32.82M +69.3% -358.7% -0.76 pp N/A N/A
    €6.85M -30.5% -€19.38M -4.7% -283.0% -0.77 pp -€29.13M -10.9% -425.3% -0.94 pp
    €9.86M -46.7% -€20.35M +3.3% -206.4% -1.0 pp -€32.71M +296.5% -331.8% -2.9 pp
    €18.51M +958.0% -€19.70M -26.0% -106.4% +14 pp -€8.25M -67.3% -44.6% +14 pp
    €1.75M -79.4% -€26.63M +45.0% -1,522.0% -13 pp -€25.22M +53.2% -1,441.4% -12 pp
    €8.49M +16.1% -€18.37M +81.1% -216.5% -0.78 pp -€16.46M +116.7% -193.9% -0.90 pp
    €7.31M +99.3% -€10.15M -13.1% -138.8% +1.8 pp -€7.59M -15.5% -103.9% +1.4 pp
    €3.67M +93.1% -€11.67M +6.4% -318.2% +2.6 pp -€8.98M +19.4% -244.9% +1.5 pp
    €1.90M +39.5% -€10.97M +71.7% -577.4% -1.1 pp -€7.52M +25.5% -396.0% +0.44 pp
    €1.36M -40.4% -€6.39M -2.5% -469.1% -1.8 pp -€6.00M +30.7% -440.3% -2.4 pp
    €2.28M -36.5% -€6.55M +14.9% -286.8% -1.3 pp -€4.59M -28.6% -200.9% -0.22 pp
    €3.60M -73.0% -€5.70M +13.1% -158.5% -1.2 pp -€6.42M -55.0% -178.6% -0.71 pp
    €13.32M -25.4% -€5.04M -46.3% -37.8% +0.15 pp -€14.28M +193.6% -107.2% -0.80 pp
    €17.84M +80.6% -€9.39M -32.6% -52.6% +0.88 pp -€4.86M -44.1% -27.3% +0.61 pp
    €9.88M +∞% -€13.93M -39.7% -141.0% -1.4 pp -€8.70M -54.7% -88.0% -0.88 pp
    €0.00 -100.0% -€23.09M +81.4% N/A -€19.19M +4.4% N/A
    €10.00M +∞% -€12.73M -37.7% -127.3% -1.3 pp -€18.38M -14.3% -183.8% -1.8 pp
    €0.00 +NaN% -€20.45M -∞% N/A -€21.43M +2.2% N/A
    €0.00 +NaN% €0.00 +NaN% N/A -€20.97M +43.4% N/A
    €0.00 €0.00 N/A -€14.62M N/A

    Notifications